Clincosm LogoSign in Get a demo

myelogenous leukemia, acute

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, Leukemia, Acute Myeloid, Myeloid Leukemia, Acute Trial in Canada, United States (Iomab-B, Conventional

Active, not recruiting
  • Acute Myeloid Leukemia
  • +8 more
  • Gilbert, Arizona
  • +23 more
Feb 22, 2022

Myelogenous Leukemia, Acute Trial in Ramat Gan (Bisantrene, Fludarabine, Clofarabine)

Recruiting
  • Myelogenous Leukemia, Acute
  • Ramat Gan, Israel
    Chaim Sheba Medical Center
Sep 21, 2021

Myelogenous Leukemia, Acute Trial in Worldwide (RO5503781 MBP, RO5503781 SDP, Idarubicin)

Completed
  • Myelogenous Leukemia, Acute
  • RO5503781 MBP
  • +4 more
  • Los Angeles, California
  • +11 more
Jan 24, 2017

Myelogenous Leukemia, Acute Trial in France, Germany, Italy (RO5429083, cytarabine)

Completed
  • Myelogenous Leukemia, Acute
  • Marseille, France
  • +7 more
Nov 1, 2016

Myelogenous Leukemia, Acute Trial in Worldwide (RO5045377, cytarabine)

Completed
  • Myelogenous Leukemia, Acute
  • Valhalla, New York
  • +8 more
Nov 1, 2016

Myelogenous Leukemia, Acute, MDS Trial in Canada, United States (MGCD0103)

Terminated
  • Myelogenous Leukemia, Acute
  • Myelodysplastic Syndromes
  • Kansas City, Missouri
  • +12 more
Jun 4, 2015

Myelogenous Leukemia, Acute Trial in Boston (gefitinib)

Completed
  • Myelogenous Leukemia, Acute
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Apr 29, 2014